We are presenting a colloquium – “Obsessive Compulsive Disorder: Getting Help and Support for Recovery” – on Wednesday, October 9, 2024 at Sacred Heart University (SHU) in Fairfield, CT. Christina J. Taylor, Ph.D., OCD Connecticut Clinical Board Advisor, and OCD Connecticut board members will discuss the symptoms, diagnosis, and treatment of OCD. The presentation is sponsored by The Human Journey Colloquia 2024 Series and is free and open to the public.

The panel will be held at 2:00 PM in the Loris Forum in the Martire Building at SHU, 5401 Park Avenue, Fairfield, CT.

Together with the Fairfield County OCD Support Group, we have organized an informal social gathering on Wednesday, August 28th. The gathering will take place at Pistachio Café 2, located at 1245 Chapel Street, New Haven, CT at 6:00pm (the cafe closes at 8:30pm). This is a decent sized spot with indoor and outdoor seating, and metered street parking. Please note there are two Pistachio Cafes in New Haven. We’ll be meeting at the one on Chapel Street, not the one on Whalley Avenue. This get-together will allow us to connect and support each other face-to-face in a relaxed environment. For more information, you can contact Amy at [email protected].

Together with the Fairfield County OCD Support Group, we have organized an informal social gathering on Tuesday, July 23rd. The gathering will take place at Maison Mathis Cafe, located at 304 Elm St, New Haven, CT at 6:00pm (the cafe closes at 9:00pm). This is a decent-sized location with indoor and outdoor seating. Metered street parking and a paid parking lot are in the center island. This get-together will allow us to connect and support each other face-to-face in a relaxed environment. For more information, you can contact Amy at [email protected].

In this NYU Langone Insights on Psychiatry podcast, Dr. Christopher Pittenger, Professor of Psychiatry at the Yale School of Medicine and Director of the Yale OCD Research Clinic, is interviewed about the biology and treatment of obsessive-compulsive disorder (OCD), including novel potential treatments such as psychedelics, neurofeedback, glutamate modulators, and transcranial magnetic stimulation (TMS). Also discussed is why OCD is so underdiagnosed and what clinicians can do to spot it.

Dr. Pittenger was a guest speaker at a recent OCD Connecticut Lecture Series event at Yale on June 18, 2024, where he discussed the same topics. Click here to go to the podcast.

Dr. Pittenger, a renowned psychiatry researcher, is a leading figure in the field. He earned his MD and Ph.D. from Columbia University and later returned to Yale University, his undergraduate alma mater, for research and residency. Pittenger’s research focuses on the brain’s role in creating thought, feeling, and consciousness, as well as how brain dysregulation leads to mental suffering. His work has been particularly focused on OCD and Tourette syndrome, and the cortico-basal ganglia circuitry. He co-founded the Yale Program for Psychedelic Science, focusing on how molecules like psilocybin and LSD can teach us about brain and behavior, potentially leading to new treatments for neuropsychiatric pathology. Pittenger is a member of the Scientific Advisory Board of the International OCD Foundation and OCD Connecticut, and a Fellow of the American College of Neuropsychopharmacology, American Psychiatric Association, and American Neurological Association.

Dr. Pittenger’s website is https://medicine.yale.edu/profile/christopher-pittenger/.
The Yale OCD Research Clinic website is https://medicine.yale.edu/psychiatry/ocd/.

Click here to download the study’s information sheet.

The OCD Advantage is an online forum created by Joseph Ettinger. Joseph has struggled with OCD his entire life. He’s been on and off medications, has done ERP therapy, and tried every tactic in the book. And now, he has completely restructured his relationship with OCD. For so long, he struggled to find an online community that truly felt like a community. He struggled to feel like he was getting to know others; there was a lack of interaction, collaboration, networking, and more. That is why he started The OCD Advantage. Joseph plans to make this the most collaborative, interactive, and networkable community to date. In time, you’ll find vibrant dialogue and collaboration, resource sharing, courses and lessons that he is putting together, virtual meet-ups, and more. But above all else, you’ll find AUTHENTIC AND LASTING FRIENDSHIPS BEING FORMED. Click here to go to the forum.

The Annual International OCD Foundation’s (IOCDF) OCD Conference brings together individuals and families living with OCD, mental health professionals, and researchers to educate and empower the community. This July, the International OCD Foundation invites you to learn about the latest treatments, research, and practices in OCD and related disorders. We can’t wait to see you in Orlando!

This year’s conference will take place in Orlando, FL on July 25-28, 2024 at the Hyatt Regency Orlando.

Welcome to the largest international conference dedicated to OCD and related disorders!

This year’s event will feature three days of in-person programming for the entire OCD community, including:

• Individuals with lived experience
• Family members & supporters
• Mental health professionals
• Researchers

IOCDF has a great lineup in store for our community. Click here to view registration rates and policies. We can’t wait to see you all!

“This is the world’s largest gathering of those who are dedicated to solving the problem of OCD. Researchers, clinicians, those with OCD, and their families all come together to teach, to learn from each other, and to share support. Whether you are looking to learn about today’s cutting-edge treatments or the best coping strategies for families, this conference is for you.” — Reid Wilson, PhD

As part of our Lecture Series, we are thrilled to announce that we are sponsoring an event featuring Christopher Pittenger, MD, PhD, director of the Yale OCD Research Clinic, as the keynote speaker. Dr. Pittenger will share his groundbreaking research on novel treatments for OCD, shedding light on the latest advancements in the field. He will also provide a comprehensive overview of the basics regarding OCD, treatment, medication, etc.

Dr. Pittenger, a renowned psychiatry researcher, is a leading figure in the field. He earned his MD and Ph.D. from Columbia University and later returned to Yale University, his undergraduate alma mater, for research and residency. Pittenger’s research focuses on the brain’s role in creating thought, feeling, and consciousness, as well as how brain dysregulation leads to mental suffering. His work has been particularly focused on OCD and Tourette syndrome, and the cortico-basal ganglia circuitry. He co-founded the Yale Program for Psychedelic Science, focusing on how molecules like psilocybin and LSD can teach us about brain and behavior, potentially leading to new treatments for neuropsychiatric pathology. Pittenger is a member of the Scientific Advisory Board of the International OCD Foundation and OCD Connecticut, and a Fellow of the American College of Neuropsychopharmacology, American Psychiatric Association, and American Neurological Association.

The event will take place on Tuesday, June 18, 2024, at 7:00 pm in the Cohen Auditorium located in the Yale Child Study Center, 230 S. Frontage Road NIHB E-02, New Haven, CT. For driving and parking directions to the Cohen Auditorium, click here.

Dr. Pittenger’s website is https://medicine.yale.edu/profile/christopher-pittenger/.
The Yale OCD Research Clinic website is https://medicine.yale.edu/psychiatry/ocd/.

If you are interested in attending, please RSVP to [email protected].

On May 15, 2024, we were honored to welcome Denis Sukhodolsky, PhD, clinical psychologist and professor at the Yale Child Study Center, to conduct a virtual Zoom presentation entitled: OCD in Children and Adolescents: Assessment, Diagnosis and Cognitive-Behavioral Therapy. Dr. Sukhodolsky spoke about the phenomenology and clinical assessment of OCD in children and adolescents. Particular attention was paid to the diagnosis of complex presentations and co-occurring neurodevelopmental disorders. In addition, principles and methods of cognitive-behavioral therapy (CBT) for OCD, also known as exposure and response prevention (ERP), were reviewed with illustrations of application to specific symptom profiles.

Dr. Sukhodolsky is a clinical psychologist and professor at the Yale Child Study Center, where he conducts research on psychotherapy for children with neurodevelopmental disorders. He also works with children and their families at the Center and teaches a course on cognitive-behavior therapy for child psychiatry fellows at the Yale School of Medicine.

His website is https://medicine.yale.edu/profile/denis-sukhodolsky/.

Dr. Sukhodolsky graciously allowed us to share his slide presentation on our website. To view the presentation, click here.

According to a recent investigation, behavioral avoidance may reduce the long-term effectiveness of exposure and response prevention (ERP), a popular treatment for OCD. Click here to read more.